Saturday 17 October 2026 Export VTGN’s income statement to Excel — free account

VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.3 million, up 161.1% from fiscal 2025. In the quarter to June 2026, revenue grew 504.9%, EPS grew 36.2% and free cash flow grew 22.2%, each against the same quarter a year earlier.

0.20 0.01 −4.76%

Follow VTGN

Alert me

Market cap: $9.5M
P/E: 0.0×
Fwd P/E: −0.5×
Dividend yield: —
F-score: 3/9
Altman Z: −16.79
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		176.02	35.28	17.10	3.95
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(9.22)	(1.58)	(1.34)	(0.67)
P/B ratio Full definition →		1.91	0.55	0.61	0.40
Price to Tangible BV Full definition →		1.91	0.55	0.61	0.40
EV/Sales Full definition →		80.51	(32.39)	(12.13)	(5.41)
EV/EBITDA Full definition →		0.00	0.36	0.21	0.19
EV/Operating CF Full definition →		(1.10)	0.42	0.23	0.22
EV/FCF Full definition →		(1.09)	0.42	0.23	0.22
Quick Ratio Full definition →		5.66	4.57	3.55	2.84
Current Ratio Full definition →		5.79	4.67	3.67	3.07
Net Debt/EBITDA Full definition →		3.83	3.15	2.70	2.36
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.01	0.01	0.02	0.05
Operating CF/Net income Full definition →		0.71	0.93	1.00	1.13
Capex/Depreciation Full definition →		0.65	0.30	0.00	0.00
Research and Development Expense of Revenue Full definition →		6,168.60%	4,694.06%	2,835.78%	738.89%
Selling, General and Administrative Expense of Revenue Full definition →		1,703.88%	1,856.77%	868.32%	265.45%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		424.81%	361.72%	191.59%	67.14%
Graham Net Nets Full definition →		0.51	1.76	1.56	2.33
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(53.52%)	(286.36%)	(321.05%)	(721.74%)
Free Cash Flow Yield Full definition →		(41.89%)	(217.18%)	(306.82%)	(631.72%)
Revenue per Share Full definition →		0.01	0.01	0.01	0.03
Operating CF per Share Full definition →		(0.38)	(0.42)	(0.43)	(0.34)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.39)	(0.42)	(0.43)	(0.34)
Cash per Share Full definition →		2.16	1.46	1.19	0.74
Shareholders Equity per Share Full definition →		1.86	1.21	0.93	0.57
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		1.86	1.21	0.93	0.57
Free Cash Flow Full definition →		(13.82)	(17.66)	(16.20)	(14.71)
Working Capital Full definition →		65.29	49.72	34.15	23.12
Capital Expenditures Full definition →		(0.06)	(0.03)	0.00	—
Net Current Asset Value Full definition →		64.34	49.11	33.90	23.06
EV/EBIT Full definition →		0.00	0.37	0.21	0.19
Capex to Sales Full definition →		0.23	0.09	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →		1.27	1.16	1.09	0.74
Average Assets Full definition →		91.71	78.68	66.45	52.33
Average Common Equity Full definition →		79.66	66.02	52.96	40.62

Fold the line items

Columns are period end dates

Stockrow Weekly